Novalgin
Recall
|
Medicines
|
20/11/2018
The marketing authorization holder has informed its supplied customers in a letter dated November 16, 2018, that isolated impurities or contamination of the film-coated tablets have been detected, which occurred during the packaging of the film-coated tablets into the blisters. The batch AV069 is therefore recalled as a precautionary measure.
| Name of the medicinal product | Novalgin Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 3192 |
| Marketing authorisation holder | Sanofi - Aventis GmbH |
| Batch number(s) | AV069 |
| Classification of the recall | 3 |
| BASG reference number | INS-640.001-2605 |
Further inquiry note
Page last modified:
12/07/2022